<style face="normal" font="default" size="100%">382 TIM-3 blockade combined with adoptive therapy of ex vivo activated NK cells after allogeneic hematopoietic stem cell transplant reduces progression of relapsed murine neuroblastoma</style>

Drupal-HighWire